Platelet dysfunction associated with ponatinib, a new pan BCR-ABL inhibitor with efficacy for chronic myeloid leukemia resistant to multiple tyrosine kinase inhibitor therapy

Bibliographic Details
Published in:Haematologica
Main Authors: Pratap Neelakantan, David Marin, Mike Laffan, John Goldman, Jane Apperley, Dragana Milojkovic
Format: Article
Language:English
Published: Ferrata Storti Foundation 2012-09-01
Online Access:https://haematologica.org/article/view/6417